Non-interventional Translational Study in Mild, Moderate and Severe Acne Patients

This study aims to uncover the specific immunopathology, microbiome and pathophysiology of acne vulgaris in people living in a tropical climate such as Singapore. This is a largely unexplored population in terms of acne pathogenesis, and will lead to population-specific interventions for the management of acne vulgaris.

NCT Number	NCT07411638
Lead Sponsor	National Skin Centre Collaborators: Sanofi, A*Star
Conditions	Acne
Enrollment	200 participants
Start Date	2026-02-15
Primary Completion	2028-02-14 (estimated)
Study Completion	2029-02-14 (estimated)
Updated on ClinicalTrials.gov	2026-02-17